Clinical Trial Update: Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating raltegravir plus maraviroc in controlled HIV patients with lipohypertrophy was terminated; the study did not proceed to further resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Lipohypertrophy

Drugs mentioned

• Maraviroc (maraviroc)
• Raltegravir (raltegravir)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Human Immunodeficiency Virus, Lipohypertrophy | Phase 2 | Status: TERMINATED